Bright Minds Biosciences Statistics

Total Valuation

DRUG has a market cap or net worth of $263.68 million. The enterprise value is $259.38 million.

Market Cap	263.68M
Enterprise Value	259.38M

Important Dates

The next estimated earnings date is Tuesday, February 11, 2025, after market close.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	n/a

Share Statistics

DRUG has 6.95 million shares outstanding. The number of shares has increased by 19.17% in one year.

Current Share Class	6.95M
Shares Outstanding	6.95M
Shares Change (YoY)	+19.17%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	59.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 35.08, with a Debt / Equity ratio of 0.00.

Current Ratio	35.08
Quick Ratio	34.75
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-536.85

Financial Efficiency

Return on equity (ROE) is -51.80% and return on invested capital (ROIC) is -30.53%.

Return on Equity (ROE)	-51.80%
Return on Assets (ROA)	-28.86%
Return on Capital (ROIC)	-30.53%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2,529.25% in the last 52 weeks. The beta is 1.13, so DRUG's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+2,529.25%
50-Day Moving Average	40.29
200-Day Moving Average	10.93
Relative Strength Index (RSI)	49.30
Average Volume (20 Days)	155,704

Short Selling Information

The latest short interest is 221,369, so 3.19% of the outstanding shares have been sold short.

Short Interest	221,369
Short Previous Month	264,763
Short % of Shares Out	3.19%
Short % of Float	8.40%
Short Ratio (days to cover)	0.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.49M
Pretax Income	-3.82M
Net Income	-2.62M
EBITDA	n/a
EBIT	-2.49M
Earnings Per Share (EPS)	-$0.63

Full Income Statement

Balance Sheet

The company has $4.52 million in cash and $10,241 in debt, giving a net cash position of $4.51 million or $0.65 per share.

Cash & Cash Equivalents	4.52M
Total Debt	10,241
Net Cash	4.51M
Net Cash Per Share	$0.65
Equity (Book Value)	4.46M
Book Value Per Share	1.00
Working Capital	4.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.89M
Capital Expenditures	n/a
Free Cash Flow	-1.80M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRUG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.17%
Shareholder Yield	-19.17%
Earnings Yield	-0.99%
FCF Yield	-0.68%

Analyst Forecast

The average price target for DRUG is $75.00, which is 94.05% higher than the current price. The consensus rating is "Buy".

Price Target	$75.00
Price Target Difference	94.05%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Jul 14, 2023
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2